Skip to main content
. 2020 Jan 28;11(2):137. doi: 10.3390/genes11020137

Table 1.

Patient Characteristics.

ID Age Gender Refraction [dpt]
(sph/cyl)
OD
OS
BCVA ODOS Gene Zygosity Exons/
Introns
Nucleotide Protein Reference
IV.3 48 m −0.75/−2.25
−0.75/−1.00
20/32
20/50
RHO het Exon 3 c.644C>T p.Pro215Leu [18]
IV.4 45 f +3.00/−2.25
+3.25/−2.50
HM
HM
ABCA4 het Exon 6 c.740A>T p.(Asn247Ile) [19]
het Exon 31 c.4594G>A p.(Asp1532Asn) [20,21]
CACNA1F het Exon 8 c.1079C>T p.(Ser360Phe) novel
V.1 13 m −1.75/−4.25
−2.75/−3.25
20/50
20/40
CACNA1F hem Exon 8 c.1079C>T p.(Ser360Phe) novel
V.2 11 m +4.50/−0.50
+6.00/−1.25
20/200
20/80
MITF het Exon 7 c.710+1G>A splice site [22]

f: female, m: male, OD: right eye, OS: left eye, BCVA: best corrected visual acuity, HM: hand motion, het: heterozygous, hem: hemizygous.